Bionano Genomics Inc
(BNGO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,376 | -18,584 | -10,510 | -29,815 | -21,914 |
| Depreciation Amortization | 909 | 591 | 296 | 1,128 | 815 |
| Accounts receivable | 1,709 | 1,795 | 1,261 | -2,375 | -1,486 |
| Accounts payable and accrued liabilities | 925 | 150 | 477 | 1,362 | 1,042 |
| Other Working Capital | -1,132 | 146 | 517 | -4,972 | -1,895 |
| Other Operating Activity | 755 | 652 | -73 | 5,142 | 3,290 |
| Operating Cash Flow | $-26,210 | $-15,250 | $-8,032 | $-29,530 | $-20,148 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -61 | -38 |
| Net Acquisitions | -2,450 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-2,450 | $N/A | $N/A | $-61 | $-38 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 761 | 760 | 761 | 5,113 | 3,084 |
| Debt Issued | 1,775 | 1,775 | N/A | 19,134 | 19,169 |
| Debt Repayment | -5,000 | -5,000 | -2,100 | -10,812 | -10,812 |
| Common Stock Issued | 36,535 | 21,453 | 2,360 | 20,559 | 2,578 |
| Other Financing Activity | -3,855 | -3,855 | -2,156 | -3,615 | -2,131 |
| Financing Cash Flow | $30,216 | $15,133 | $-1,135 | $30,379 | $11,888 |
| Beginning Cash Position | 17,311 | 17,311 | 17,311 | 16,523 | 16,523 |
| End Cash Position | 18,867 | 17,194 | 8,144 | 17,311 | 8,225 |
| Net Cash Flow | $1,556 | $-117 | $-9,167 | $789 | $-8,298 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,210 | -15,250 | -8,032 | -29,530 | -20,148 |
| Capital Expenditure | N/A | N/A | N/A | -61 | -38 |
| Free Cash Flow | -26,210 | -15,250 | -8,032 | -29,591 | -20,186 |